2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎

2020-01-22 欧洲抗风湿病联盟 Ann Rheum Dis. 2020 Jan 22.

2020年1月,欧洲抗风湿病联盟(EULAR)发布了应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎指南,本文主要提供了更新的类风湿关节炎管理建议,共包括5条总体原则和12条具体推荐意见。

中文标题:

2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎

英文标题:

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

发布机构:

欧洲抗风湿病联盟

发布日期:

2020-01-22

简要介绍:

2020年1月,欧洲抗风湿病联盟(EULAR)发布了应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎指南,本文主要提供了更新的类风湿关节炎管理建议,共包括5条总体原则和12条具体推荐意见。

 

拓展指南:类风湿性关节炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎)] GetToolGuiderByIdResponse(projectId=1, id=142071c001860069, title=2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎, enTitle=EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update., guiderFrom=Ann Rheum Dis. 2020 Jan 22., authorId=null, author=, summary=2020年1月,欧洲抗风湿病联盟(EULAR)发布了应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎指南,本文主要提供了更新的类风湿关节炎管理建议,共包括5条总体原则和12条具体推荐意见。 , cover=, journalId=null, articlesId=null, associationId=258, associationName=欧洲抗风湿病联盟, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jan 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月,欧洲抗风湿病联盟(EULAR)发布了应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎指南,本文主要提供了更新的类风湿关节炎管理建议,共包括5条总体原则和12条具体推荐意见。 </P> <P> </P>拓展指南:<strong>与<font color=red>类风湿性关节炎</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=7adab1c00180117d" title="2019 NICE诊断指南:类风湿性关节炎TNF-α抑制剂治疗监测(DG.36)" target=_blank>2019 NICE诊断指南:类风湿性关节炎TNF-α抑制剂治疗监测(DG.36)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b0c4f1c001e9a274" title="2019 HKSR共识建议:类风湿性关节炎的管理" target=_blank>2019 HKSR共识建议:类风湿性关节炎的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bed7e1c001e12a8a" title="2018 APLAR建议:类风湿性关节炎的治疗(更新版)" target=_blank>2018 APLAR建议:类风湿性关节炎的治疗(更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d67fd1c0016836cc" title="2018 意大利共识建议:类风湿性关节炎丙型肝炎感染的管理" target=_blank>2018 意大利共识建议:类风湿性关节炎丙型肝炎感染的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c4c9e1c00165282c" title="2018 SFR建议:类风湿性关节炎的管理(更新)" target=_blank>2018 SFR建议:类风湿性关节炎的管理(更新)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%B1%BB%E9%A3%8E%E6%B9%BF%E6%80%A7%E5%85%B3%E8%8A%82%E7%82%8E" target=_blank>有关类风湿性关节炎更多指南</a></ul>, tagList=[TagDto(tagId=2259, tagName=类风湿性关节炎), TagDto(tagId=1113, tagName=药物治疗)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10089, appHits=528, showAppHits=7, pcHits=2901, showPcHits=8158, likes=26, shares=24, comments=16, approvalStatus=1, publishedTime=Tue Feb 04 21:52:24 CST 2020, publishedTimeString=2020-01-22, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Feb 04 21:52:24 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 18:39:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎)])
2019 EULAR建议:应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1202009, encodeId=2f8b1202009bc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Sat Mar 12 15:02:53 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978939, encodeId=75dd9e89392c, content=实用性很强<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:08:47 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966242, encodeId=3054966242ea, content=实用性很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Mon May 17 13:01:59 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966141, encodeId=178e9661414d, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/2c79e9fb0b4e42eaad9864b59438f404/dd06f2199bc249ee93f07ba857242ac6.jpg, createdBy=0c285501916, createdName=南宫婉的留恋, createdTime=Mon May 17 06:12:14 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951326, encodeId=38a6951326cf, content=10积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f51e5456530, createdName=ms9000000810563456, createdTime=Fri Mar 26 08:52:28 CST 2021, time=2021-03-26, status=1, ipAttribution=)]
    2022-03-12 ms9000001273668370

    好东西

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1202009, encodeId=2f8b1202009bc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Sat Mar 12 15:02:53 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978939, encodeId=75dd9e89392c, content=实用性很强<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:08:47 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966242, encodeId=3054966242ea, content=实用性很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Mon May 17 13:01:59 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966141, encodeId=178e9661414d, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/2c79e9fb0b4e42eaad9864b59438f404/dd06f2199bc249ee93f07ba857242ac6.jpg, createdBy=0c285501916, createdName=南宫婉的留恋, createdTime=Mon May 17 06:12:14 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951326, encodeId=38a6951326cf, content=10积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f51e5456530, createdName=ms9000000810563456, createdTime=Fri Mar 26 08:52:28 CST 2021, time=2021-03-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1202009, encodeId=2f8b1202009bc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Sat Mar 12 15:02:53 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978939, encodeId=75dd9e89392c, content=实用性很强<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:08:47 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966242, encodeId=3054966242ea, content=实用性很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Mon May 17 13:01:59 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966141, encodeId=178e9661414d, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/2c79e9fb0b4e42eaad9864b59438f404/dd06f2199bc249ee93f07ba857242ac6.jpg, createdBy=0c285501916, createdName=南宫婉的留恋, createdTime=Mon May 17 06:12:14 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951326, encodeId=38a6951326cf, content=10积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f51e5456530, createdName=ms9000000810563456, createdTime=Fri Mar 26 08:52:28 CST 2021, time=2021-03-26, status=1, ipAttribution=)]
    2021-05-17 ms1000000861491970

    实用性很强

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1202009, encodeId=2f8b1202009bc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Sat Mar 12 15:02:53 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978939, encodeId=75dd9e89392c, content=实用性很强<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:08:47 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966242, encodeId=3054966242ea, content=实用性很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Mon May 17 13:01:59 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966141, encodeId=178e9661414d, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/2c79e9fb0b4e42eaad9864b59438f404/dd06f2199bc249ee93f07ba857242ac6.jpg, createdBy=0c285501916, createdName=南宫婉的留恋, createdTime=Mon May 17 06:12:14 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951326, encodeId=38a6951326cf, content=10积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f51e5456530, createdName=ms9000000810563456, createdTime=Fri Mar 26 08:52:28 CST 2021, time=2021-03-26, status=1, ipAttribution=)]
    2021-05-17 南宫婉的留恋

    好东西

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1202009, encodeId=2f8b1202009bc, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Sat Mar 12 15:02:53 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978939, encodeId=75dd9e89392c, content=实用性很强<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3505535937, createdName=ms1000000783007837, createdTime=Fri Jul 02 11:08:47 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966242, encodeId=3054966242ea, content=实用性很强, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Mon May 17 13:01:59 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966141, encodeId=178e9661414d, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210514/2c79e9fb0b4e42eaad9864b59438f404/dd06f2199bc249ee93f07ba857242ac6.jpg, createdBy=0c285501916, createdName=南宫婉的留恋, createdTime=Mon May 17 06:12:14 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951326, encodeId=38a6951326cf, content=10积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f51e5456530, createdName=ms9000000810563456, createdTime=Fri Mar 26 08:52:28 CST 2021, time=2021-03-26, status=1, ipAttribution=)]
    2021-03-26 ms9000000810563456

    10积分

    1

    展开1条回复